Form 10-Q CURIS INC For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Curis (CRIS) Outpaces in Q3; Roth Affirms 'Buy' Rating Ahead of ASH
November 9, 2015 2:54 PM ESTRoth Capital reaffirms Curis (Nasdaq: CRIS) with a Buy rating and $5 price target following Q3 results and update issued earlier Monday.
Analyst Joseph Pantginis noted that Curis posted Q3 loss of $0.04 per share, versus the firm's outlook calling for a loss of $0.08 per share.
Pantginis continued, INDs for both licensed programs from Aurigene are... More
